Abstract
BackgroundIn the realm of cancer immunotherapy, immune cell-based treatments utilizing monocytes-derived macrophages and dendritic cells (DCs) have emerged as a formidable force. These phagocytic antigen-presenting cells (APCs) hold immense potential...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have